By using our website, you agree to the use of cookies as described in our Cookie Policy.

Close
Consilium-white-out.png Consilium Final logo.png Menu
Close
Twitter
  • About Us
    • Healthcare
    • Our values
  • Our expertise
    • Overview
      • Overview
    • Our experience
    • Case studies
      • Alliance for Regenerative Medicine
      • Sensyne Health
      • Cancer Research UK
      • Cambridge Innovation Capital
      • Vectura
      • CMR Surgical
      • Horizon Discovery
      • Immunocore
      • Quanta
  • Our team
  • News & insights
    • Consilium news
    • Consilium Conscience
    • Monthly intel
    • Events calendar
    • Email Alerts
  • Careers
  • Contact us

Healthcare newsletter

  • Home/
  • News & insights/
  • Monthly intel/
  • Newsletter

News & insights

  • Consilium news
  • Consilium Conscience
  • Monthly intel
  • Events calendar
  • Email Alerts
Tweets by ConsiliumHC

Skip to our monthly intel

2021 HAS STARTED AT CONSILIUM MUCH LIKE 2020 ENDED:
M&A, PROMOTIONS AND NEW HIRES 

By Mary-Jane Elliott

At this point in a new year, many of us would be returning from a grueling schedule of meetings at the JP Morgan Healthcare Conference. Instead, this year, the fiber optic networks have been burning red hot as we’ve replaced bumping into each other on the hills of San Francisco with Zoom calls. Although media attention on the annual industry gathering has been more subdued than in typical years, the sentiment from clients is that schedules are packed with investor and partnering meetings and the world has adapted, just like it did throughout 2020.

At Consilium, COVID-19 still dominates the agenda for our clients. The ability of the sector to respond to the crisis has been breathtaking and it is has proven itself to be central to global attempts to get us back to normality. Investors and most governments are committed to recognising where support is needed to develop products and their commitment is not diminishing. 
The appetite for healthcare innovation outside of COVID-19 is not abating. Proven by the active M&A market with three of our clients being acquired in the past few weeks: in late December 2020, we saw the agreed takeover of Horizon Discovery by Perkin Elmer for $383 million  complete . In January Arvelle Therapeutics was acquired by Angelini Pharma  for a total aggregate valuation of up to $960 million and Kymab was acquired by Sanofi for up to $1.45 billion with $1.1bn of that being up front – that’s the largest ever UK acquisition of a private healthcare company.

Behind the screens of Consilium, we have also seen notable changes. 2021 started with the promotion of Matthew Neal to Partner. This first internal promotion to Partner reflects our growth and maturation as a business as well as demonstrating our commitment to professional development and the recognition of talent. Alongside Matthew’s promotion, Priscila Radu, has been promoted to Associate and this followed a whole series of hires and promotions in 2020. To further support our growing business, we have also appointed two new Senior Associate Partners; we welcome Allison Connolly from Bloomberg and welcome back on old friend, Jessica Hodgson.
As we are not able to meet in person during these times, we have launched our new blog page, Consilium Conscience to update you on what’s happening in the healthcare sector, the capital markets, as well as at Consilium. As part of this, we have also launched a vlog and there will be a lot more digital content coming your way over the coming weeks and months.


Thank you to all our clients and collaborators for your continued support an importantly, to the Consilium team who continue to work tirelessly, keeping a sense of humour and positivity in these challenging times. We wish all our stakeholders a safe and successful 2021.d, most

Get the latest company updates from Consilium:

LinkedIn

Movers and Shakers

See the latest City movers and shakers

close

Movers and Shakers

  • Advanced Medical Solutions appointed Grahame Cook as a Non-Executive Director
  • Silence Therapeutics appointed Craig Tooman as CFO and Michael H. Davidson to its Board of Directors
  • Achilles Therapeutics appointed Arjan Roozen as VP, Site Head and General Manager
  • Modulus Oncology appointed Tim Edwards as Chairman
  • MeMed appointed Troy Boutelle as VP of Commercial in North America
  • Candel Therapeutics appointed Paul-Peter Tak as President and CEO, Nathan Caffo as CBO, John Canepa as CFO and Susan Stewart as CRO
  • iRhythm Technologies appointed Mike Coyle as CEO
  • Sage Therapeutics appointed Barry Greene as CEO
  • Myovant Sciences appointed Dave Marek as CEO
  • Pfizer appointed Aida Habtezion as CMO
  • ObsEva appointed David Renas as CFO
  • MorphoSys appointed Sung Lee as CFO
  • Checkmate Pharmaceuticals, Inc. appointed Robert Dolski as CFO
  • 4D Molecular Therapeutics, Inc. appointed Robert Fishman as CMO
  • Immune Regulation Ltd. appointed Jones Woody Bryan as CBO
  • Evelo Biosciences, Inc. appointed Jonathan Zung as CDO
  • AdrenoMed AG appointed Wolfgang Baike as CEO
  • Pharma Two B Ltd. appointed Sheila Oren as CEO
  • Union Therapeutics A/S appointed Kim Domela Kjoeller as CEO
  • Myovant Sciences Ltd. appointed David C. Marek as CEO and Director
  • PDS Biotechnology Corp. appointed Seth L. van Voorhees as Chief Financial and Accounting Officer
  • CASI Pharmaceuticals, Inc. appointed Weihao Xu as Chief Financial and Accounting Officer
  • Shanghai Henlius Biotech, Inc. appointed Xin Lei Li as CFO and Vice President
  • Lykan Bioscience LLC appointed Patrick K. Lucy as CEO and President
  • Cornerstone Therapeutics, Inc. appointed Jon Zwinski as CEO and President
  • Immune Regulation Ltd. appointed Pericles Calias as COO
  • Inventiva SA appointed Michael P. Cooreman as CMO
  • Inhibikase Therapeutics, Inc. appointed C. Warren Olanow as CMO
  • Immune Regulation Ltd. appointed Jeff Myers as CMO
  • FibroGen, Inc. appointed Mark Eisner as CMO
  • Saniona AB appointed Denelle J. Waynick as CLO
  • Yumanity Therapeutics, Inc. appointed Paulash Mohsen as CFO and CBO and Marie N. Epstein as CAO
  • Vincera Pharma, Inc. appointed Ahmed Hamdy as CEO, President and Chairman

Fundraising highlights

Highlighted fundraising activity this month

close

Fundraising highlights

Company Name

Amount Raised

Type of Fundraise

Country

Date

Public company financings

Gracell Biotechnologies Inc.

$209 million

IPO

China

9-Jan-21

Inhibikase Therapeutics Inc.

$18 million

IPO

US

31-Dec-20

Arvinas Inc.

$400 million

Follow-on

US

17-Dec-20

AbCellera Biologics Inc.

$555.5 million

IPO

Canada

11-Dec-20

Private company Financings

Immunocore

$75 million

Series C

UK

11-Jan-21

Theolytics Ltd.

$6.8 million

Series A

UK

8-Jan-21

Abbisko Therapeutics Co. Ltd.

$123 million

Series D

China

8-Jan-21

DiCE Molecules SV LLC’s

$80 million

Series C

US

8-Jan-21

LifeMine Therapeutics Inc.

$50 million

Series B

US

8-Jan-21

Aulos Bioscience

$40 million

Series A

US

8-Jan-21

Mana Therapeutics Inc.

$35 million

Series A

US

8-Jan-21

Affinivax Inc.

$236 million

Series C

US

8-Jan-21

Lexeo Therapeutics

$85 million

Series A

US

7-Jan-21

Werewolf Therapeutics Inc.

$72 million

Series B

US

7-Jan-21

Senti Biosciences

$105 million

Series B

US

6-Jan-21

Immuneering Corp.

$62 million

Series B

US

5-Jan-21

Terns Pharmaceuticals Inc.

$87 million

Series C

US

5-Jan-21

Ikena Oncology Inc.

$120 million

Series B

US

5-Jan-21

Transcenta Holding Ltd.

$105 million

Cross-over

China

31-Dec-20

Risen (Shanghai) Pharmaceutical Technology Co. Ltd

$61.1 million

Series B

China

31-Dec-20

Aivita Biomedical Inc.

$25 million

Series B-2

US

31-Dec-20

Aegicare (Shenzhen) Technology Co. Ltd.

$15.4 million

Series B

China

31-Dec-20

Eccogene (Shanghai) Co. Ltd.

$15.4 million

Undisclosed

China

31-Dec-20

Immunochina Pharmaceutical Co. Ltd.

Undisclosed

Series C++

China

31-Dec-20

ImmVira Co. Ltd.

Undisclosed

Series C

China

31-Dec-20

AliveX

Undisclosed

Angel round

China

31-Dec-20

Galixir

Undisclosed

Undisclosed

China

31-Dec-20

Neomorph Inc.

$109 million

Series A

US

22-Dec-20

ONL Therapeutics Inc.

$46.9 million

Series B

US

21-Dec-20

Virtue Diagnostics (Suzhou) Co. Ltd.

$2 million

Series A

China

21-Dec-20

Peptilogics Inc.

$35.4 million

Series B

US

21-Dec-20

Raynovent Biotech Co.

$42.9 million

Series B

China

21-Dec-20

SomaLogic Inc

$81 million

Series A

US

21-Dec-20

Peptomyc S.L.

$13.8 million

Series B

Spain

17-Dec-20

Neurogene Inc.

$115 million

Series B

US

17-Dec-20

Atsena Therapeutics

$55 million

Series A

US

17-Dec-20

MinervaX

$57.6 million

Undisclosed

Denmark

17-Dec-20

Vivace Therapeutics Inc.

$30 million

Series C

US

17-Dec-19

Locanabio Inc.

$100 million

Series B

US

15-Dec-19

Rani Therapeutics LLC

$69 million

Series E

US

15-Dec-19

CG Oncology Inc.

$47 million

Series D

US

15-Dec-19

Denovo Biopharma LLC

$45.8 million

Series D

US

15-Dec-19

Biosion Inc.

$30.6 million

pre-Series B

China

15-Dec-19

HighTide Biopharmaceutical Ltd.

Undisclosed

Series B

China

15-Dec-19

InnoSkel

$24.3 million

Series A

France

14-Dec-19

Nuance Biotech

$181 million

Series D

China

9-Dec-19

Pear Therapeutics Inc.

$80 million

Series D

US

9-Dec-19

PepGen Ltd.

$45 million

Series A

UK

9-Dec-19

Vigil Neuroscience Inc.

$50 million

Series A

US

9-Dec-19

GenoImmune Therapeutics

$15.3 million

Series A+

China

9-Dec-19

OBiO Technology (Shanghai) Co.

$15.3 million

Series C+

China

9-Dec-19

Accutar Biotechnology Inc.

Undisclosed

Undisclosed

US

9-Dec-19

Deepcell Inc.

$20 million

Series A

US

9-Dec-19

RayzeBio

$105 million

Series B

US

8-Dec-19

Analyst directory

View our Analyst Directory

close

Analyst directory

Bank

Analyst

ABG Sundal Collier

Morten Larsen, Daniel Thorsson

ABN AMRO

Mark van der Geest, Rene Verhoeff

Alm. Brand Markets

Michael Friis Jørgensen

AlphaValue

Armelle Moulin, Marion Scherzinger

Banco de Sabadell, S.A.

Javier Esteban

Banco Espirito Santo de Investimento

Luis Navia

Bank am Bellevue

Bruno Eschli, Stephen Leventhal

Bankhaus Lampe KG

Heiko Feber, Frank Neumann

Bank Vontobel AG

Carla Baenziger

Barclays

Hassan Al-Wakeel, Blanka Porkolab, Emily Field, Jameel Bakhsh, Brian Balchin, Peter Lawson

Berenberg Bank

Scott Bardo, Luisa Hector, Kerry Holford, Tom Jones, Ravi Misra, Xian Deng, Michael Healy, Esther Hong, Iris Zhilin Long, Zhiqiang Shu, Yun Zhong (David Hogg)

Bank of America Merrill Lynch

Aspen Mori (NY), Graham Parry (London), Qian Weng, John Aldersley (Dan Lundquist)

Bryan, Garnier & Co

Dylan van Haaften, Eric Le Berrigaud, Ross Blair, Mickael Chane-Du, Marion Levi, Hugo Solvet, Vincent Meunier, (Dominic Wilson)

CA Cheuvreux

Marcel Brand, Laurent Flamme, Richard Koch, Oliver Reinberg

Caja Madrid Bolsa

Ana Isabel González García

Carnegie Bank

Niels Granholm, Philip Lagnetoft, Kristofer Liljeberg-Svensson, Carsten Lonborg Madsen, Henrik Sinding, Lars Topholm

Cenkos Securities

Chris Donnellan

Citigroup

Liav Abraham (US), Andrew Baum, Alex Glasner, Peter Verdult, Patrick Wood, (David Rawley)

CM-CIC Securities

Agnès Blazy, Arsene Guekam

Commerzbank

Volker Braun, Daniel Wendorff

Cowen International

David Kirkpatrick, Ritu Baral, Ryan Blicker, Ken Cacciatore, Marc Frahm, Joshua Jennings, Chris Lin, Charles Rhyee, Doug Schenkel, Yaron Weber

Credit Suisse

Christoph Gretler, Evan Seigerman, Matt Miksic Barbora Blaha, Jo Walton, Matthew Weston, (Phil Gestrin)

Danske Equities

Thomas Bowers, Mattias Häggblom, Hans Jeppsson, Martin Parkhøi, Søren Samsøe

Deutsche Bank

Emmanuel Papadakis, Rajan Sharma, Justin Bowers, Jack McKibben, Farzana Habib, Katie Kraft, Jeremy Finkelstein, Andrew Vincent

Degroof Petercam

Thomas Guillot, Benoit Louage, Chris Keepers

DnB NOR

Rune Dahl

DZ Bank

Christa Bähr, Elmar Kraus, Thomas Maul, Peter Spengler

Edison

John Priestner, Susie Jana, John Savin, Jonas Peciulis, Sean Conroy, Maxim Jacobs, Nathaniel Calloway

, Pooya Hemami

Equinet Institutional Services

Edouard Aubery

Equity Development

Emma Ulker

Exane BNP Paribas

Richard Parkes, Alex Evans, Julien Dormois, Hugo Solvet, Nicolas Langlet, Kartik Swaminathan

fairesearch GmhH & Co

Martin Schnee

finnCap

Mark Brewer, Arshad Ahad, Nik Lysiuk

Goetz Partners

Melina Reisenberg, Chris Redhead

Goldman Sachs

Krishna-Chaitanya Arikatla, Veronika Dubajova, Divya Harikesh, Keyur Parekh, Graig Suvannavejh, Joanna Tucka, Kira Huppertz,  (Mick Readey)

Handelsbanken Capital Markets

Klaus Madsen, Björn Olander, Peter Sehested

Hardman and Co

Martin Hall, Gregoire Pave

Helvea

Daniel Jelovcan, Odile Rundquist, Olav Zilian

HSBC

Steve McGarry, Julie Mead, Lucy Acton, Murielle André-Pinard

ING

Sjoerd Ummels, David Vagman

Investec

Andrew Whitney, Jens Lindqvist, (Brough Ransom)

Jefferies

Harry Sephton, Grace Lee, Lucy Codrington, Philippa Gardner, Kit Lee, Ken Rumph, James Vane-Tempest, Peter Welford, Ing Shen Tan, Erin Primdahl, (Jan Scherer)

JP Morgan Cazenove

David Adlington, Alex Comer, James Gordon, Richard Vosser, Marjan Daeipour

KBC Securities

Sandra Cauwenberghs, Lenny Van Steenhuyse

Kempen & Co

Alexander Cogut, Rene Wouters, Suzanne van Voorthuizen, Ingrid Gafanhão, Sebastiaan van der Schoot

Kepler Capital Markets

Arsene Gekam, Damien Choplain, David Evans, Maja Pataki, Martin Voegtli,  Matthias Maenhaut

Landesbank Baden-Wuerttemberg

Timo Kuerschner

Liberum Capital

Alistair Campbell, Graham Doyle

Morgan Stanley

Alex Gibson, Michael Jungling, Simon Mather, Jenny Leeds

N+1 Singer

Chris Glasper, Edward Thomason, Sahill Shan

Natixis Beatrice

Philipe Lanone, Jean-Jacques  Le Fur

Nordea Markets

Klas Pyk

Nord/LB

Holger Fechner, Thorsten Strauss

Numis

Paul Cuddon, Stefan Hamill, (Ceri Morgan)

Oddo Securities

 

Martial Descoutures, Oussama Denguir

Panmure Gordon

Mike Mitchell, Julie Simmonds, (David Cox)

Pareto Securities

Finlay Heppenstall, Ulrik Trattner

Peel Hunt

Miles Dixon, Anchal Verma, Amy Walker

Portzamparc Gestion S.A.

Christophe Dombu

RBC Capital Markets

Zoe Karamanoli (maternity), Charles Weston, Jack Reynolds-Clarke

Redburn

Simon Baker, Darshan R., Issie Kirby, Charles Pitman, Robert Shore, Ed Ridley-Day

Rx Securities

Samir Devani, Joseph Hedden, Michael King, Ross Blair

Sanford C Bernstein

Lisa Clive

Santander

Rebecca McClellan, Alejandro Conde Fraisolí, Tomasz Krukowski,

SEB Enskilda

Lars Hevreng, Henrik Simonsen, Peder Strand

Shore Capital

Adam Barker, Tara Raveendran

Société Générale

Florent Cespedes,

Patrick Jousseaume, Delphine Le Louët, Justin Smith

Standard & Poors

Sho Matsubara, Jacob Thrane

Stifel

Christian Glennie, Max Herrmann, James Osborne (Erland Sternby)

Swedbank

Johan Unnerus

Trinity Delta

Lala Gregorek, Franc Gregori

UBS

Laura Sutcliffe, Michael Leuchten, Jack Scannell, Sebastien Walker

Zürcher Kantonalbank

Michael Nawrath

Media directory

View our Media Directory

close

Media directory

BBC Fergus Walsh, Hugh Pym, James Gallagher, Katie Hope, Alex Therrien

Boston Business Journal Lucy Maffei, Don Seiffert, Max Stendahl

Boston Globe Jonathan Saltzman

Boston Herald Jordan Graham

Business Insider Erin Bromley, Lydia Ramsey, Zach Tracer

Daily Express Mark Atherton, Becky Fletcher, Giles Sheldrick

Daily Mail Vanessa Chalmers, Jonathan Chadwick, Ethan Ennals, Anna Hodgekiss, Fiona Macrae, Matt Oliver, Rachel Reilly, Ben Spencer, Alexandra Thompson, Sally Wardle, Victoria Woollaston

Daily Telegraph, Julia Bradshaw, Laura Donnelly, Anne Gulland, Sarah Knapton, Chloe Lambert, Hannah Uttley, Hannah Boland, Jon Yeomans, Louise Moon

Financial Times Clive Cookson, Darren Dodd, Anna Gross, Sarah Neville, Gill Plimmer, Barney Thompson (UK); Hannah Kuchler (US)

Forbes Steve Brozak, Bruce Japsen, Leah Rosenbaum

Fortune Sy Mukherjee

Inc. Kimberly Weisul

Mail on Sunday Stephen Adams, Joanne Hart, Eve Simmons, Alex Lawson

Sky News Mark Kleinman, Paul Kelso, Thomas Moore

The Guardian Sarah Boseley, Denis Campbell, Hannah Devlin, Natalie Grover, Julia Kollewe, Linda Geddes

The New York Times Gina Kolata, Andrew Pollack, Sabrina Tavernise, Katie Thomas

The Sunday Times John Collingridge, Andrew Gregory, Jonathan Leake, Sabah Meddings, Lois Rogers, Oliver Shah, Jamie Nimmo

The Times Philip Aldrick, Kaya Burgess, Richard Fletcher, Tom Howard, Graham Ruddick, Kat Lay, Fiona MacRae, Alex Ralph, Dominic Walsh

The Wall Street Journal Brian Gormley, Daniela Hernandez, Jared Hopkins (US); Robert Lee Hotz, Stefanie Ilgenfritz, Peter Loftus (US); Amy Dockser Marcus, Jonathan Rockoff (US); Denise Roland (Europe, maternity leave); John Simons, Joseph Walker, Jeanne Whalen, Anna Wilde Mathews (US)

The Washington Post Carolyn Johnson

S&P Global Etain Lavelle, Kristen Hallam

 

APM Health Europe Nick Hudson, Thomas Meek, Natalie Morrison, Eliza Slawther

Associated Press Tom Murphy

Bloomberg Naomi Kresge (Berlin); Albertina Torsoli (Geneva); John Lauerman (Boston), James Paton (London); Drew Armstrong (New York); Marthe Fourcade (Paris); Tim Loh (Munich)

Dow Jones Matteo Castia, Ian Walker, Philip Waller

fastFT Jennifer Thompson

Thomson Reuters Kate Kelland, Paul Sandle

 

AnimalPharm Joseph Harvey

BioCentury Stephen Hansen (UK); Jonathan Block, Paul Bonanos, Jeff Cranmer, Simone Fishburn, Dave Flores, Virginia Li, Chris Lieu, Lauren Martz, Erin McCallister, Alicia Parker, Susan Schaeffer, Mark Zipkin (US)

BioWorld MedTech Bernard Banga, John Brosky, David Godkin, Larry Haimovitch, Stacy Lawrence, Nuala Moran, Katie Pfaff

BioWorld Shannon Ellis, Michael Fitzhugh, John Fox, Brian Orelli, Randy Osborne, Alfred Romann, Tamra Sami, Cormac Sheridan, Nuala Moran

Endpoints Arsalan Arif, John Carroll, Jason Mast, Amber Tong, Conner Mitchell

Genome Web Ben Butkus, Molika Ashford, Monica Heger, Madeleine Johnson

Fierce Life Sciences Ben Adams, Nick Paul Taylor (UK); Amirah Al Idrus, Michael Gibney, Conor Hale, Carly Helfand, Mark Hollmer, Emily Mullin, Eric Palmer, Tracy Staton, Emily Wasserman (US)

FirstWord Medtech Tina Tan

Healthcare Business International Max Hotopf

HealthInvestor Jonathan Bacon, Vernon Baxter, Sunniva Davies-Rommetveit, Catherine Llewllyn, Jenna Lomax, Ploy Radford

IN VIVO Lucie Ellis (UK); Ben Comer (US)

Investors Chronicle Harriet Clarfelt, Emma Powell, Mark Robinson

Labiotech Clara Rodríguez Fernández, Jonathan Smith

MedCityNews Alaric DeArment

MedNous Victoria English, Karen Finn

Medtech Insight Jenny Blair, Philip Greenfield (UK); Reed Miller (US)

Nature Biotechnology Lisa Melton

Pharmaphorum Catherine Longworth, Richard Staines, George Underwood

PharmaTimes Selina McKee, Anna Smith

Scrip John Davis, Kevin Grogan, Eleanor Malone, Andrew McConaghie, Alex Shimmings (UK); Joseph Haas, Mandy Jackson, Mary Jo Laffler, Jessica Merrill, Denise Peterson (US); Anju Ghangurde, Ian Haydock (Asia-Pacific)

Shares Magazine Martin Gamble

Sifted Michael Stothard, John Thornhill, Maija Palmer, Amy Lewin, Chris Sisserian, Isabel Woodford, Nicolas Colin, Kitty Knowles (UK), Mimi Billing, Tim Smith (Spain), Tom Turula (Sweden), Marie Mawad (France)

STAT Adam Feuerstein, Damian Garde, Matthew Herper, Meghana Keshavan, Rebecca Robbins, Ed Silverman, Mario Aguilar, Katie Palmer

The Economist Catherine Brahic, Slavea Chankova, Alice Fulwood, Alok Jha, Natasha Loder

The Pink Sheet Neena Brizmohun, Francesca Bruce, Maureen Kenny, Ian Schofield, Vibha Sharma (UK); Nielsen Hobbs, Sue Sutter (US)

Timmerman Report Luke Timmerman

Vantage Lisa Urquhart, Madeleine Armstrong, Amy Brown, Elizabeth Cairns, Jacob Plieth (UK)

Xconomy Alex Lash, Frank Vinluan, Greg Huang


Back to previous page
Twitter
Register for news and updates Line
  • Twitter
  • LinkedIn
  • Email

©2021 Consilium Strategic Communications

  • Accessibility
  • Privacy and cookie policy
  • Sitemap

emperor.works